Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Roche, multiple sclerosis
US FDA approves injectable version of Roche's multiple sclerosis therapy
The U.S. Food and Drug Administration on Thursday approved Roche's under-the-skin injection to treat patients with multiple sclerosis. The therapy is already approved as an infusion or IV therapy for multiple sclerosis,
Therapeutic inertia in the treatment of women with multiple sclerosis revealed
A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of childbearing age.
Roche's OCREVUS ZUNOVO Gets FDA Approval To Treat Relapsing And Progressive Multiple Sclerosis
Swiss drug major Roche (RHHBY) announced Monday that the United States Food and Drug Administration has approved OCREVUS ZUNOVO
FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug
Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has its own injectable MS drug, Kesimpta.
Roche Gets FDA Approval for Multiple-Sclerosis Treatment
Roche Holding's Genentech unit said the Food and Drug Administration approved its twice-yearly, subcutaneous injection treatment for patients with two types of multiple sclerosis. The treatment, called Ocrevus Zunovo,
MedPage Today on MSN
17h
Higher Comorbidity Burden in Multiple Sclerosis Tied to Worse Outcomes
"Those with the highest burden of comorbidity had over a 30% increased risk of having disability worsening," Salter said. "In ...
Multiple Sclerosis News Today
1d
ECTRIMS 2024: Mavenclad sustains benefits in relapsing MS
A short course of Mavenclad can provide long-term reductions in disease activity and disability progression in highly active ...
BUCKSCO.Today on MSN
8h
Local Multiple Sclerosis Advocate Honored With State Citation
Bucks County resident Joseph “Smiley” Terinoni was recently presented with a citation from the Pennsylvania House of ...
1d
on MSN
Early treatment significantly reduces long-term disability in children with multiple sclerosis, new study finds
New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that ...
News Medical on MSN
1d
$1 Million Grant to Fund Research of Nerve Regeneration in Multiple Sclerosis Patients
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Medscape
5d
Does Multiple Sclerosis Protect Against Alzheimer's?
Patients with MS showed half the rate of amyloid pathology compared with people without MS, suggesting a possible protective ...
1d
on MSN
Ancestry-specific genetic variants linked to multiple sclerosis risk
A study has uncovered novel ancestry-specific genetic variants linked to multiple sclerosis (MS), offering new insights that ...
News Medical
2d
Study uncovers ancestry-specific genetic links to multiple sclerosis risk
A landmark study has uncovered novel ancestry-specific genetic variants linked to
multiple sclerosis
(MS), offering new insights that could reshape treatment approaches for diverse populations ...
21h
Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years
Novartis' new data for Kesimpta showed reduced disability progression in relapsing multiple sclerosis patients. Continuous ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
OCREVUS
MS
Food and Drug Administration
TG Therapeutics
IBD
Feedback